SRI Biosciences' toxicology and pharmacokinetics services meet worldwide standards and regulatory requirements for investigational new drug (IND) applications. All services fully comply with the U.S. Food and Drug Administration’s Good Laboratory Practice (GLP) regulations. We offer:
- Discovery ADMET and In Vitro Metabolism
- Drug Metabolism and Pharmacokinetics
- Toxicology and Safety
- Safety Pharmacology
- Genetic Toxicology
- Developmental and Reproductive Toxicology
Division:
SRI Biosciences
Focus Areas:
Biomedical Sciences + Health News + Events
Our Innovators
 Senior Director, Toxicology and Pharmacokinetics |
 Director of Preclinical Safety, SRI Biosciences |
 Managing Director, Division Operations, and Director, Preclinical Development |
 Director, General Toxicology |
